Home Contact Sitemap login Checkout

BioAlberta
  • Home
  • About
    • About
    • The BioAlberta Team
    • From The President
    • What We Do
    • Board of Directors
    • Committees
    • Industry Partners
    • Hall Of Fame
  • Talent Hub
    • Talent Hub
    • Alberta Petri Dish
    • WIL
    • Boosting Biotech
  • Industry Facts
    • Industry Facts
    • Medical Technology & Devices
    • Health Biotechnology & Pharmaceuticals
    • Agricultural Biotechnology
    • Industrial Biotechnology
    • Functional Foods & Natural Health Products
    • Environmental Biotechnology
    • Industry Terms
  • Events
    • Events
    • Alberta at Bio International 2022
    • Annual Events & Activities
    • Archived Events
      • Archived Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
      • 2017 Events
      • 2016 Events
      • 2015 Events
      • 2014 Events
  • News
    • News
    • Archived News
      • Archived News
      • 2020 News
      • 2019 News
      • 2018 News
      • 2017 news
      • 2016 News
      • 2015 News
      • 2014 News
  • Member Area
    • Member Area
    • Member Marketplace
    • Join Now
    • Member Benefits
      • Member Benefits
      • How To Access Member Benefits
    • Current Members and Life Sciences Industry
    • Current Members by Category
    • Profiled Company
      • Profiled Company
      • Previously Profiled Companies
  • Resources
    • Resources
    • Other Resources
  • Contact
Print This Page

The Alberta Multiple Sclerosis (MS) Collaboration:  Piloting the Alberta Neuroscience Collaborative

Supporting MS research and translation

Edmonton, 10 March 2016 - The Alberta MS Collaboration was announced at the Kaye Edmonton Clinic before an audience of distinguished guests, including: Dr. V. Wee Yong, Alberta MS Network Director; Dr. Fabrizio Giuliani, Medical Director, MS Clinic, Kaye Edmonton Clinic;  Dr. Samuel Weiss, Chair of the Steering Committee, Campus Alberta Neuroscience; Dr. Peter Brenders, GM sanofi-genyne and the Associate Minister of Health Brandy Payne.  The pilot project was established to boost the province’s capacity for MS research and translation, and to provide a focused approach of the research for the benefit of Albertans.

This investment is being made by the Government of Alberta, in partnership with Campus Alberta Neuroscience, the Alberta MS Network and Sanofi Genzyme Canada.

 

Read full press release details.

Contact Us
Suite 202
10055 - 106 Street NW
Edmonton, Alberta T5J 2Y2
Canada
Ph:  780.425.3804
Fx:  780.409.9263
admin@BioAlberta.com
Quick Links
Home
About
Industry Facts
News
Events
Member Area
Publications
Contact
Return Policy
Privacy
Terms of Use
Connect
BioAlberta: Twitter linkBioAlberta: linkedin linkBioAlberta: YouTube linkBioAlberta: facebook link